From innovation to market adoption in the operating room: The “CFO as customer”

Dr Egeland is senior director of business development and licensing in the Early Technologies business unit of the Minimally Invasive Therapies Group at Medtronic. Mr Rapp is an associate consultant at Pharmagellan, a biotech consultancy. Dr David is the founder and managing director of Pharmagellan...

Full description

Saved in:
Bibliographic Details
Published inSurgery Vol. 162; no. 3; pp. 477 - 482
Main Authors Egeland, Ryan D., MD, PhD, MBA, Rapp, Zachary, MA, David, Frank S., MD, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2017
Subjects
Surgery
Online AccessGet full text

Cover

More Information
Summary:Dr Egeland is senior director of business development and licensing in the Early Technologies business unit of the Minimally Invasive Therapies Group at Medtronic. Mr Rapp is an associate consultant at Pharmagellan, a biotech consultancy. Dr David is the founder and managing director of Pharmagellan.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0039-6060
1532-7361
DOI:10.1016/j.surg.2017.04.007